Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
基本信息
- 批准号:10552700
- 负责人:
- 金额:$ 77.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibioticsBacterial InfectionsBiological AssayBlood CirculationCandidaCandida albicansCandidiasisCathetersCell CountCellsClinicalCollecting CellCritical IllnessDevicesDiseaseDrug TargetingDrug resistanceEffectivenessEnvironmentFoundationsGenerationsGeneticGenetic DeterminismGrowthHealth Care CostsHealthcareHeterogeneityHuman bodyImmunocompromised HostIn VitroIncidenceIndividualInfectionInterventionLibrariesLifeLiquid substanceMeasurementMeasuresMethodsMicrobial BiofilmsMicrofluidic MicrochipsMicrofluidicsMorbidity - disease rateMycosesNeoplasm MetastasisOilsPatientsPharmaceutical PreparationsPhenotypePhysiologicalPreventionProcessPropertySepsisSiteSolidSurfaceSystemTechnologyTherapeuticVirulenceVirulence FactorsWettabilityWorkYeastsattributable mortalitycandida biofilmcandidemiafungusin vitro Assayin vivoinnovationinstrumentationmortalitymutantnoveloperationpathogenic fungusscreeningtool
项目摘要
Project Summary/Abstract
Opportunistic fungal pathogens are a leading cause of healthcare associated bloodstream infections. Candida
yeasts, specifically, cause 80-90% of biofilm-associated invasive fungal infections and mortality rates can
approach 50%. Furthermore, the incidence of Candida infections is rising with the increased use of catheter and
other device-based interventions. To date, the majority of work related to fungal infections and potential
treatments has focused on biofilms and their prevention. However, recent evidence suggests that the dispersion
of yeast cells from the biofilm (into the bloodstream) and the persistence of these dispersed cells are
perhaps more important virulence factors and represent significant but underutilized treatment targets.
Further, existing assays and instrumentation are not amenable to measuring dispersion and phenotyping
dispersed cells. Nor do they recapitulate in vivo conditions (e.g. flow, interaction with host cells). Thus, here we
will develop a new type of under-oil open microfluidic system (UOMS) to quantify the dispersive capacity of
biofilms and assess the phenotype of dispersed cells in Candida mutants and clinical isolates. The UOMS
platform is built on the foundation of a newly observed phenomena called Exclusive Liquid Repellency (ELR).
ELR provides a unique environment where liquid is completely repelled from a solid surface to eliminate
biofouling. Additionally, ELR expands the capabilities of simple open microfluidic devices allowing us to
overcome the limitations of current methods and provide a system capable of quantitatively studying fungal
dispersion. We will first (Aim 1) develop an under-oil microchannel device to measure the dispersive capacity of
Candida biofilms and virulence phenotypes. Second (Aim 2) we will automate the UOMS and develop a single-
cell distribution assay to measure the phenotype of individual dispersed cells. And finally (Aim 3), we will use the
UOMS platform to develop dispersion phenotype profiles for Candida mutant libraries and clinical isolates. We
will measure the dispersive capacity and phenotype of dispersed cells from hundreds of Candida albicans clinical
isolates and mutants available in existing libraries, providing clues to the genetic determinants of dispersion.
项目摘要/摘要
机会性真菌病原体是医疗保健相关血流感染的主要原因。念珠菌
酵母菌尤其引起80%-90%的与生物膜相关的侵袭性真菌感染和死亡率
接近50%。此外,随着导管和导管的使用增加,念珠菌感染的发生率也在上升
其他基于设备的干预。到目前为止,大多数与真菌感染和潜在的
治疗的重点是生物被膜及其预防。然而,最近的证据表明,这种分散
酵母细胞从生物膜(进入血液)和这些分散的细胞的持久性是
也许是更重要的毒力因素,代表着重要但未得到充分利用的治疗目标。
此外,现有的分析和仪器不适用于测量分散度和表型。
分散的细胞。它们也不概括体内的条件(例如,流动,与宿主细胞的相互作用)。因此,在这里,我们
将开发一种新型的油下开放式微流控系统(UOMS)来量化石油的分散能力
并评估念珠菌突变株和临床分离株中分散细胞的表型。UOMS
平台建立在一种新观察到的现象的基础上,这种现象被称为排他性液体排斥(ELR)。
ELR提供了一种独特的环境,在这种环境中,液体完全从固体表面排斥以消除
生物污垢。此外,ELR扩展了简单开放式微流控设备的功能,使我们能够
克服当前方法的局限性,提供一种能够定量研究真菌的系统
分散。我们将首先(目标1)开发一种油下微通道装置来测量石油的分散能力
念珠菌生物被膜和毒力表型。第二(目标2)我们将使UOMS自动化,并开发一个单一的-
细胞分布试验测量单个分散细胞的表型。最后(目标3),我们将使用
UOMS平台,开发念珠菌突变体库和临床分离株的分散表型图谱。我们
将测量数百株临床白色念珠菌分散细胞的分散能力和表型
现有文库中可用的分离株和突变体,为分散的遗传决定因素提供线索。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J Beebe其他文献
Molecular analysis of antigen presentation machinery in circulating tumor cells from renal cell carcinoma and prostate cancer
- DOI:
10.1186/2051-1426-1-s1-p57 - 发表时间:
2013-11-01 - 期刊:
- 影响因子:10.600
- 作者:
Joshua M Lang;Jacob T Tokar;Jamie Sperger;Benjamin P Casavant;Scott M Berry;Lindsay N Strotman;David J Beebe - 通讯作者:
David J Beebe
David J Beebe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J Beebe', 18)}}的其他基金
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
开发人体肠道微生理系统用于研究原生动物寄生虫的免疫反应
- 批准号:
10733303 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
- 批准号:
10333399 - 财政年份:2021
- 资助金额:
$ 77.08万 - 项目类别:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
- 批准号:
10209529 - 财政年份:2021
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
9916997 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
10331769 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
微环境介导的癌细胞表面靶向治疗耐药机制
- 批准号:
10686449 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
10094211 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
微环境介导的癌细胞表面靶向治疗耐药机制
- 批准号:
10263962 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
用于实时分析儿科免疫细胞功能的多重微量测定
- 批准号:
10380807 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
用于实时分析儿科免疫细胞功能的多重微量测定
- 批准号:
10132990 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Research Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
ARC Future Fellowships
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 77.08万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Studentship














{{item.name}}会员




